Results 21 to 30 of about 49,090 (277)

Case Report: Safe and Effective Sublingual Birch Allergen Immunotherapy in Two HIV-Positive Patients

open access: yesFrontiers in Immunology, 2021
Allergen-specific immunotherapy (AIT) is a safe, effective treatment for respiratory allergies (such as moderate-to-severe allergic rhinoconjunctivitis) that are not controlled by symptomatic medications.
Elena Latysheva   +3 more
doaj   +1 more source

Characterization of Immune Cells in Oral Tissues of Non-human Primates

open access: yesFrontiers in Oral Health, 2022
The oral mucosa contains distinct tissue sites with immune niches capable of either immunogenic or tolerogenic responses. However, immune cell compositions within oral mucosal tissues at homeostasis have not been well-characterized in human relevant ...
Jamie L. Hernandez   +6 more
doaj   +1 more source

Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells

open access: yesFrontiers in Immunology, 2020
Application of allergens onto the sublingual epithelium is used to desensitize allergic individuals, a treatment known as sublingual immunotherapy. However, the response of sublingual epithelial cells to house dust mite allergen and potential tolerance ...
Michael P. Pelst   +8 more
doaj   +1 more source

Sublingual Lymph Node Metastasis in Early-Stage Floor of the Mouth Carcinoma [PDF]

open access: yes, 2017
Sublingual lenf nodlarına metastaz oral kavite kanserlerinde çok nadirdir. Bu olgu sunumunda sublingual lenf nodu metastazı olan erken evre ağız tabanı kanserli bir olgu sunulmuştur. Sublingual lenf nodlarına metastaz oranları düşükse de, erken evre ağız
Göksel Turhal   +5 more
core   +1 more source

EFFICACY AND SAFETY OF SUBLINGUAL IMMUNOTHERAPY IN ALLERGIC ASTHMA AMONG CHILDREN AND ADOLESCENTS INTERVENTIONAL STUDY [PDF]

open access: yesJournal of Environmental Science, 2021
Background: bronchial asthma is a chronic inflam­matory disorder with bronchial hyper-responsiveness. Environmental exposure in sensitized individuals is a major inducer of Allergy-associated asthma in children and adults, sublingual immunotherapy (SLIT)
Mohamed E. Osman   +2 more
doaj   +1 more source

Sublingual misoprostol vs. oral misoprostol solution for induction of labor: A retrospective study

open access: yesFrontiers in Surgery, 2022
IntroductionInduction of labor (IOL) is one of the most common obstetrical procedures, with an increasing rate. The prostaglandin E1 analogue misoprostol is frequently used as a primary method of labor induction.
Mahdi Amini   +3 more
doaj   +1 more source

Dermoids of the Maxillofacial Region: A study on clinical presentation and surgical management

open access: yesIndian Journal of Dental Sciences, 2022
Introduction: Dermoid and epidermoid cysts commonly termed as “Dermoids” are known to be developmental benign swellings that possibly occur as a result of traumatic implantation of epithelium or entrapment of epithelial remnants during embryonic fusion ...
Divashree Sharma   +3 more
doaj   +1 more source

Sublingual Dosage Form [PDF]

open access: yes, 2023
Sublingual dosage forms have gained significant attention in the field of pharmaceuticals due to their unique route of administration and rapid onset of action.
Namrata S. Revar*, Samruddhi B. Sawant, Sanjeevani D. Rupwate
core   +1 more source

Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Background: Allergen-specific immunotherapy (AIT) is safe and effective for the treatment of allergic rhinitis and allergic asthma. However, patient non-compliance is a major barrier to achieving optimal outcomes Objective: To determine the level of ...
Fardous Musa   +3 more
doaj   +1 more source

Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study

open access: yesDrug Delivery, 2021
Flibanserin (FLB) was approved by FDA for the treatment of pre-menopausal female hypoactive sexual desire disorder (HSDD). FLB suffers from low oral bioavailability (33%) which might be due to hepatic first-pass metabolism in addition to its poor aqueous
Marianne J. Naguib, Amal I. A. Makhlouf
doaj   +1 more source

Home - About - Disclaimer - Privacy